[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 256
Citations 0
Comment & Response
August 27, 2014

Bioprosthetic Valves for Transcatheter Aortic Valve Replacement

Author Affiliations
  • 1Department of Cardiothoracic Surgery, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas
JAMA. 2014;312(8):844-845. doi:10.1001/jama.2014.8364

To the Editor The CHOICE trial1 is the first randomized trial comparing balloon-expandable and self-expandable valves for TAVR. This trial used the VARC definition of device success as a composite primary end point. It found a higher device success with the balloon-expandable valve, driven largely by a lower frequency of aortic regurgitation. There are several serious flaws in the trial design that call these conclusions into question.

First Page Preview View Large
First page PDF preview
First page PDF preview
×